Short answer: Both are sold for blood sugar. NIH calls chromium's effect in diabetes slight and of unclear clinical meaning, with mixed trials.1 Berberine lowered fasting glucose and HbA1c against placebo in a 20-trial review,2 though stomach upset is common.3 No trial has compared the two alone; the one trial with both gave them together.4
| Chromium | Berberine | |
|---|---|---|
| What it is | A trace mineral; supplements usually use chromium picolinate1 | A plant compound; the main active part of the herb Rhizoma Coptidis5 |
| Main review | 28 trials in type 2 diabetes: fasting glucose 19 mg/dL lower and HbA1c 0.71 points lower than control, with very mixed results between trials6 | 20 placebo-controlled trials (1,761 people, with and without diabetes): fasting glucose 0.52 mmol/L lower, HbA1c 4.48 mmol/mol lower2 |
| NIH or guideline view | Slight drops of unclear clinical meaning; the American Diabetes Association does not recommend it1 | No NIH fact sheet found in the sources checked |
| Larger single trials | 137 adults, 1,000 mcg a day for 24 weeks: no overall change in insulin sensitivity, glucose or HbA1c vs placebo17 | 36 adults, 0.5 g three times a day vs metformin for 3 months: similar glucose lowering3 |
| Side effects | Rare case reports of liver, kidney, muscle and blood problems; no upper limit set because data are limited1 | Passing stomach and gut upset in 34.5% of patients in one pilot study3 |
| Head-to-head trial | None found | None found |
NIH describes one often-cited 1997 trial in 180 adults with type 2 diabetes in which 1,000 mcg a day lowered fasting glucose and HbA1c vs placebo, then says later trials were inconsistent. A 2019 review of 58 trials found small drops in fasting glucose and HbA1c of unclear clinical meaning.1 A 2020 meta-analysis of 28 trials found larger average drops, but the results varied hugely between trials.6 In a careful 24-week trial, chromium did not help most people; the few who responded had worse insulin resistance and higher glucose to begin with.7
The FDA allows only a qualified claim for chromium picolinate, calling a link to lower diabetes risk highly uncertain. NIH also notes chromium may lower levothyroxine absorption if taken at the same time.1
A 2023 review of 20 placebo-controlled trials found lower fasting glucose, HbA1c, fasting insulin and insulin resistance on berberine, with bigger glucose drops in people with diabetes and in Asian populations; the authors called the effects modest.2 A 2021 review of 46 trials, many testing berberine added to standard diabetes treatment, found HbA1c 0.73 points lower than control.5 In an early pilot, 0.5 g three times a day lowered glucose about as much as metformin in 36 adults over 3 months, and 34.5% of patients had passing gut side effects.3
The only randomized trial in our search with both gave berberine, white mulberry leaf and chromium together in one product, so it cannot say which part did what.4
On the numbers, berberine's placebo-controlled evidence is more consistent than chromium's, but no trial has put them side by side, and neither replaces diabetes treatment. If you take insulin or other diabetes medicines, ask your prescriber before adding either, because lower blood sugar on top of medicine can go too low. This is general information, not personal advice. More detail: the Chromium (Chromium Picolinate) and Berberine guides, and Berberine vs metformin: how do they compare?.